Remove x
article thumbnail

Healthcare & Life Sciences Private Equity Deal Tracker: Windjammer Acquires Bio X Cell

JD Supra: Mergers

Windjammer Capital has announced it has acquired Bio X Cell (BXC). BXC, founded in 1997 and based in Lebanon, N.H., is a producer of monoclonal antibodies for use in both in vivo and in vitro pre-clinical research applications. By: McGuireWoods LLP

article thumbnail

MarketAxess relaunches Mid-X offering in Europe

The TRADE

MarketAxess has re-launched Mid-X in Europe, providing anonymous matching sessions at the mid-point price within the region. Mid-X leverages the MarketAxess Open Trading network which offers access to a pool of sell-side and ETF liquidity to maximise matching opportunities.

Trading 64
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Windjammer snaps up biotech firm Bio X Cell

PE Hub

Bio X Cell was founded by Dr. Klaus Lubbe in 1997. The post Windjammer snaps up biotech firm Bio X Cell appeared first on PE Hub.

77
article thumbnail

Bill Ackman reportedly said he would 'absolutely' do a deal with X with his new SPARC funding vehicle

CNBC: Investing

Bill Ackman would 'absolutely' do a deal with X with his new SPARC funding vehicle, he told The Wall Street Journal.

Funds 145
article thumbnail

How to Package and Price Embedded Analytics

Just by embedding analytics, application owners can charge 24% more for their product. How much value could you add? This framework explains how application enhancements can extend your product offerings. Brought to you by Logi Analytics.

article thumbnail

M&G Investments leads $30 million Series B funding round for GFO-X

The TRADE

M&G Investments has led a $30 million Series B funding round for FCA-authorised digital asset derivatives venue GFO-X. The strategic investment will assist GFO-X with its forthcoming launch and support future innovation in the regulated digital asset sector.

article thumbnail

Allianz Trade x Inclusive Brains: AI + Neurotech for Inclusiveness

Global Banking & Finance

Allianz Trade x Inclusive Brains: AI + Neurotech for Inclusiveness Allianz Trade & Inclusive Brains join forces to foster the inclusion of people with disabilities thanks to AI and neurotechnologies Allianz Trade, the world’s leading trade credit insurer and Inclusive Brains, a French start-up developing a new generation of neural interfaces powered (..)

Trading 40